Dosimetric Evaluation of Sequential Boost versus Simultaneously-Integrated Boost in Patients with Breast Cancer Post Breast-Conserving Surgery
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- To evaluate the dosimetric plans in patients treated with two distinct boost techniques
研究概览
简要总结
Radiation therapy has been an integral part of the management of Breast Cancer (BC). Radiation to Breast is complicated by the anatomy and relationship of target volumes with nearby organs at risk (OARs). With advances in technology, various techniques such as Intensity Modulated Radiation Therapy (IMRT) and Helical Tomotherapy (HT) have led to better coverage and conformity of target volumes and side by side, reduction in dose to OARs and thereby reducing the toxicity profile. In this study, we aim to analyse the dosimetric data of our institute comparing Sequential Boost (SEQB) with Simultaneously-Integrated Boost (SIB) plans of our patients treated with IMRT and HT treatment techniques.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- Female
入选标准
- •Age more than 18 years Female patients Biopsy proven invasive breast cancer Post operative breast cancer patients having standard indication of radiation therapy.
排除标准
- •Prior radiotherapy to breast Recurrent disease Metastatic disease.
结局指标
主要结局
To evaluate the dosimetric plans in patients treated with two distinct boost techniques
时间窗: To evaluate the dosimetric plans in patients treated with two distinct boost techniques | i.e. SIB and SEQBs
i.e. SIB and SEQBs
时间窗: To evaluate the dosimetric plans in patients treated with two distinct boost techniques | i.e. SIB and SEQBs
次要结局
- To evaluate the dose received by Planning Target Volume (PTV) and Organs at Risk((OAR) during IMRT and HT techniques in breast cancer patients treated via:)
研究者
Dr Rahul Thakur
Max Super Specialty Hospital